OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Daniel Javitt

1 Projects | 1 Researchers | $300,000 Invested

2014

Trustees of Columbia University in the City of New York

Daniel Javitt, MD, PhD

Neurophysiological biomarkers for AD drug development

  • Funding Amount: $300,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed